Literature DB >> 26953075

Subclinical arterial and cardiac damage in white-coat and masked hypertension.

Wiktoria Wojciechowska1, Katarzyna Stolarz-Skrzypek1, Agnieszka Olszanecka1, Łukasz Klima1, Jerzy Gąsowski2, Tomasz Grodzicki2, Kalina Kawecka-Jaszcz1, Danuta Czarnecka1.   

Abstract

The study aimed to compare arterial and echocardiographic parameters in subjects with newly diagnosed masked (MH) or white-coat hypertension (WCH) to subjects with sustained normotension or sustained hypertension, defined according to the 2014 European Society of Hypertension practice guidelines for ambulatory blood pressure (BP) monitoring. We recruited 303 participants (mean age 46.9 years) in a family-based population study. SpaceLabs monitors and oscillometric sphygmomanometers were used to evaluate ambulatory and office BP, respectively. Central pulse pressure (PP) and aortic pulse-wave velocity (PWV) were measured with pulse-wave analysis (SphygmoCor software). Carotid intima-media thickness (IMT) and cardiac evaluation were assessed by ultrasonography. Analysing participants without antihypertensive treatment (115 sustained normotensives, 41 sustained hypertensives, 20 with WCH, 25 with MH), we detected significantly higher peripheral and central PP, PWV, IMT and left ventricular mass index in hypertensive subgroups than in those with sustained normotension. The differences between categories remained significant for peripheral PP and PWV after adjustment for confounding factors, including 24 h systolic and diastolic BP. Participants with WCH and MH, defined according to strict criteria, had more pronounced arterial and heart involvement than normotensive participants. The study demonstrates a high prevalence of these conditions in the general population that deserves special attention from physicians.

Entities:  

Keywords:  Ambulatory blood pressure monitoring; arterial stiffness; left ventricle diastolic dysfunction; left ventricular hypertrophy; masked hypertension; white-coat hypertension

Mesh:

Year:  2016        PMID: 26953075     DOI: 10.3109/08037051.2016.1150563

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  6 in total

Review 1.  White Coat Hypertension: to Treat or Not to Treat?

Authors:  Cesare Cuspidi; Carla Sala; Guido Grassi; Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2016-11       Impact factor: 5.369

2.  Association of thyroid function with white coat hypertension and sustained hypertension.

Authors:  Peng Cai; Yan Peng; YuXi Chen; Li Li; Wei Chu; Yan Wang; Xukai Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-04-11       Impact factor: 3.738

3.  Hypertension-mediated organ damage in masked hypertension.

Authors:  Alan L Hinderliter; Feng-Chang Lin; Laura A Viera; Emily Olsson; J Larry Klein; Anthony J Viera
Journal:  J Hypertens       Date:  2022-04-01       Impact factor: 4.844

Review 4.  Novel Approaches to Investigate One-Carbon Metabolism and Related B-Vitamins in Blood Pressure.

Authors:  Amy McMahon; Helene McNulty; Catherine F Hughes; J J Strain; Mary Ward
Journal:  Nutrients       Date:  2016-11-11       Impact factor: 5.717

5.  Masked hypertensives: A disguised arterial stiffness population.

Authors:  Christina Antza; Ioannis Doundoulakis; Stella Stabouli; Konstantinos Tziomalos; Vasilios Kotsis
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09-09       Impact factor: 3.738

Review 6.  Effect of white-coat hypertension on arterial stiffness: A meta-analysis.

Authors:  Peng Cai; Yan Peng; Yan Wang; Xukai Wang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.